|

Renal Autologous Cell Therapy (REACT/ rilparencel) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Prokidney1

Indications

  • Type 2 Diabetes Mellitus1
  • Chronic Kidney Diseases1
  • Diabetes1

Huntsville, Alabama1 trial

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Nephrology Consultants

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.